On Monday, Moderna Inc (MRNA.O) said its COVID-19 vaccine which generated a strong immune response in children aged six to 11 years and that it plans to submit the data to global regulators soon. Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and
On Thursday, the U.S. Centers for Disease Control and Prevention (CDC) recommended the COVID-19 vaccine boosters for recipients of the Moderna Inc (MRNA.O) and Johnson & Johnson (JNJ.N) shots, and said Americans can choose a different shot from their original inoculation as a booster. CDC director
A booster dose of the COVID-19 vaccine developed by Pfizer Inc (PFE.N) and German partner BioNTech SE (22UAy.DE) was 95.6% effective against the coronavirus when compared to a vaccinated group that did not get the third shot, data from a large study released by the companies showed on Thursday. The
